Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03239.x/fullpdf
Reference12 articles.
1. Prevention of hepatitis B flare-up during chemotherapy using Lamivudine: case report and review of the literature;Al-Taie;Annals of Haematology,1999
2. Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma;Clark;Annals of Oncology,1998
3. A revised European-American classification of malignant lymphoid neoplasms: a proposal from the International Lymphoma Study Group;Harris;Blood,1994
4. Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan;Kumagai;Annals of Oncology,1997
5. A one-year trial of lamivudine for chronic hepatitis B;Lai;New England Journal of Medicine,1998
Cited by 81 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Referral system has a diminished difference in the risk for hepatic encephalopathy development among each etiology in patients with acute liver injury;Hepatology Research;2022-01-28
2. Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents;Journal of the Formosan Medical Association;2021-09
3. Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma;BMJ Case Reports;2021-07
4. Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research;Canadian Journal of Gastroenterology and Hepatology;2021-01-08
5. Hepatitis B Virus Reactivation and Management of Patients Undergoing Immunosuppression;Hepatitis B Virus and Liver Disease;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3